Sedana Medical AB (publ) reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was SEK 37.29 million compared to SEK 26.87 million a year ago. Net income was SEK 1.42 million compared to net loss of SEK 11.15 million a year ago. Basic earnings per share from continuing operations was SEK 0.01 compared to basic loss per share from continuing operations of SEK 0.11 a year ago. Diluted earnings per share from continuing operations was SEK 0.01 compared to diluted loss per share from continuing operations of SEK 0.11 a year ago.
For the six months, sales was SEK 75.07 million compared to SEK 60.52 million a year ago. Net loss was SEK 14.7 million compared to SEK 30.12 million a year ago. Basic loss per share from continuing operations was SEK 0.15 compared to SEK 0.3 a year ago. Diluted loss per share from continuing operations was SEK 0.15 compared to SEK 0.3 a year ago.